Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Pharmacokinetic Characteristics of Different Doses of Naltrexone Implants in Patients With Alcohol Use Disorders

NCT05919017 is registered in ClinicalTrials.gov with Shenzhen Sciencare Medical Industries Co., Ltd. as lead sponsor.

NCT NCT05919017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05919017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Pharmacokinetic Characteristics of Different Doses of Naltrexone Implants in Patients With Alcohol Use Disorders
Lead sponsor
Shenzhen Sciencare Medical Industries Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
June 16, 2023
Completion date
May 1, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aud